Mannosylated PAMAM G2 dendrimers mediated rate programmed delivery of efavirenz target HIV viral latency at reservoirs
In this current research, we conceptualized a novel nanotechnology-enabled synthesis approach of targeting HIV-harboring tissues via second-generation (G2) polyamidoamine (PAMAM) mannosylated (MPG2) dendrimers for programmed delivery of anti-HIV drugs efavirenz (EFV) and ritonavir (RTV). Briefly, he...
Saved in:
Main Authors: | Rohini Kharwade (Author), Mohsin Kazi (Author), Nilesh Mahajan (Author), Payal Badole (Author), Sachin More (Author), Asaad Kayali (Author), Md Noushad Javed (Author), Mohammed Kaleem (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity of Hexyl Acrylate Modified PAMAM Dendrimer
by: Mohammad Ashkan Naderian, et al.
Published: (2018) -
Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer
by: David E. Ybarra, et al.
Published: (2022) -
Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers
by: Hidetoshi Arima
Published: (2021) -
An Alternative Approach for Acetylation of Amine Terminated Polyamidoamine (PAMAM) Dendrimer
by: Surya Prakash Gautam, et al.
Published: (2015) -
Ecotoxicity of a potential drug nano-formulation: PAMAM-dendrimer and minocycline
by: C. Blaise, et al.
Published: (2014)